Shaoli Li

Guangzhou University

H指数:23

被引数:1,942

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Uncovering the spatial patterns and internal vitality heterogeneity of bedroom communities: Evidence from Guangzhou

揭示卧城的空间格局与内部活力异质性：来自广州的证据

Cities

IF6.6

2026-04-060

PRE

Carbon reduction effects of bike-sharing and metro integration: Spatial patterns and disparities across trip purposes

共享单车与地铁整合的碳减排效应：基于出行目的的空间格局与差异

Journal of Transport Geography

IF6.3

2026-04-060

PRE

Beyond Ribosomal Mutations: Identification of MPN_080 as a Novel ATPase-Dependent Determinant of Macrolide Resistance in Mycoplasma pneumoniae

超越核糖体突变：鉴定MPN_080为一种新型的ATP酶依赖性大环内酯耐药决定因子，在肺炎支原体中。

Microorganisms

IF4.2

2026-04-050

OAAI

Construction and Validation of a Simplified Bone Age Assessment Method Based on Three Key Bones from the TW3 system

基于TW3系统三块关键骨骼的简化骨骼年龄评估方法的构建与验证

Endocrine

IF2.9

2026-04-020

PRE

Metabolic Dysfunction-Associated Fatty Liver Disease and Bone Mineral Density in School-Aged Children in China: A Propensity Score-Matched Analysis

代谢功能障碍相关脂肪肝疾病与中国学龄儿童的骨密度：一项倾向性评分匹配分析

Nutrients

IF5

2026-02-130

OAAI

Redox phenotype confers T cell-exclusion microenvironment and resistance to immunotherapy by suppressing STING/MDA5 expression and interferon signaling in lung cancers harboring KEAP1/STK11 mutations

氧化还原表型通过抑制含KEAP1/STK11突变的肺癌中STING/MDA5表达和干扰素信号传导，赋予T细胞排斥性微环境并导致对免疫治疗的抵抗。

Frontiers in Oncology

IF3.3

2025-11-250

OAAI

Case Report: Treatment response of SQSTM1–ALK fusion lung adenocarcinoma to multiple ALK inhibitors

病例报告：SQSTM1–ALK融合肺腺癌对多种ALK抑制剂的疗效反应

Frontiers in Pharmacology

IF4.8

2025-09-230

OAAI

Impact of Omicron infection on childhood health: the Beijing long-COVID study

FRONTIERS IN PUBLIC HEALTH

IF3.4

2025-02-190

OAAI

Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy

BMC CANCER

IF3.4

2024-08-200

OAAI

Associations of Obstructive Sleep Apnea Risk with Obesity, Body Composition and Metabolic Abnormalities in School-Aged Children and Adolescents

NUTRIENTS

IF5

2024-07-251

OAAI

Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis

EUROPEAN PSYCHIATRY

IF6.7

2024-03-152

OAAI

Uncommon Presentation of COVID-19: XBL Variant

ARCHIVOS DE BRONCONEUMOLOGIA

IF9.2

2023-09-011

OAAI

Circulating T-cell subsets discrepancy between bipolar disorder and major depressive disorder during mood episodes: A naturalistic, retrospective study of 1015 cases

CNS NEUROSCIENCE & THERAPEUTICS

IF5

2023-07-252

Psychological consequences among veterans during the COVID-19 pandemic: A scoping review

PSYCHIATRY RESEARCH

IF3.9

2023-06-012

OAAI

Relationships between antibiotic exposure and asthma in adults in the United States: results of the National Health and Nutrition Examination Survey between 1999 and 2018

FRONTIERS IN PUBLIC HEALTH

IF3.4

2023-04-273

OAAI

Isomaltooligosaccharides inhibit early colorectal carcinogenesis in a 1,2-dimethylhydrazine-induced rat model

FRONTIERS IN NUTRITION

IF5.1

2022-09-154

OAAI

Plasma Orexin-A Levels in Patients With Schizophrenia: A Systematic Review and Meta-Analysis

FRONTIERS IN PSYCHIATRY

IF3.2

2022-05-254

OAAI

Overexpression of BIT33_RS14560 Enhances the Biofilm Formation and Virulence of Acinetobacter baumannii

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-04-256

OAAI

Metformin acts on the gut-brain axis to ameliorate antipsychotic- induced metabolic dysfunction

二甲双胍作用于肠-脑轴以改善抗精神病药引起的代谢功能障碍

BIOSCIENCE TRENDS

IF5

2021-10-316

Quantitative proteomics analysis of Mycoplasma pneumoniae identifies potential macrolide resistance determinants

肺炎支原体的定量蛋白质组学分析确定了潜在的大环内酯类耐药决定因素

AMB EXPRESS

IF3.7

2021-02-127

OAAI

Shaoli Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向